BUPRENORPHINE AND NALOXONE

BUPRENORPHINE AND NALOXONE was reported 1249 times

BUPRENORPHINE AND NALOXONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ABSTAINS FROM RECREATIONAL DRUGS 1 0.3333
1 FOREIGN BODY EMBOLISM 10 0.3125
2 THERMOPHOBIA 1 0.0526
3 NEUROSTIMULATOR REMOVAL 1 0.0417
4 NEONATAL COMPLICATIONS OF SUBSTANCE ABUSE 1 0.0385
5 DISSEMINATED GONOCOCCAL INFECTION 1 0.0370
6 DRUG DEPENDENCE, ANTEPARTUM 1 0.0192
7 MISCARRIAGE OF PARTNER 1 0.0182
8 URINE CANNABINOIDS INCREASED 1 0.0175
9 PRODUCT DOSAGE FORM ISSUE 8 0.0166
10 TONSILLAR ERYTHEMA 1 0.0152
11 LOOSE ASSOCIATIONS 1 0.0139
12 ANTICHOLINERGIC EFFECT 1 0.0133
13 VENA CAVA INJURY 1 0.0109
14 PILOERECTION 11 0.0100
15 EYELID MYOCLONUS 1 0.0100
16 GLOMERULONEPHRITIS ACUTE 2 0.0097
17 MESENTERIC VASCULAR INSUFFICIENCY 1 0.0091
18 ABDOMINAL REBOUND TENDERNESS 1 0.0089
19 RHESUS INCOMPATIBILITY 1 0.0083
20 ANTISOCIAL PERSONALITY DISORDER 1 0.0078
21 BRIEF RESOLVED UNEXPLAINED EVENT 1 0.0076
22 PRODUCT SOLUBILITY ABNORMAL 36 0.0071
23 DRUG WITHDRAWAL MAINTENANCE THERAPY 1 0.0071
24 HETEROPHORIA 1 0.0069
25 INFECTIVE GLOSSITIS 1 0.0064
26 RESTLESS ARM SYNDROME 1 0.0064
27 OPIATES POSITIVE 3 0.0063
28 NEPHROANGIOSCLEROSIS 1 0.0062
29 SCROTAL ERYTHEMA 1 0.0060
30 ACUTE RIGHT VENTRICULAR FAILURE 1 0.0059
31 TOOTH HYPOPLASIA 1 0.0057
32 DEPENDENT PERSONALITY DISORDER 1 0.0055
33 GLOMERULONEPHRITIS CHRONIC 1 0.0053
34 STREPTOCOCCAL URINARY TRACT INFECTION 1 0.0052
35 CORTISOL ABNORMAL 1 0.0050
36 SYMPATHOMIMETIC EFFECT 1 0.0043
37 ANORECTAL OPERATION 1 0.0042
38 CHILD NEGLECT 1 0.0041
39 VICTIM OF CHILD ABUSE 1 0.0040
40 PURPURA FULMINANS 1 0.0039
41 PRODUCT TAMPERING 7 0.0039
42 CHILD ABUSE 1 0.0039
43 CYANOSIS CENTRAL 1 0.0038
44 PATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0037
45 INFUSION SITE THROMBOSIS 1 0.0037
46 EAR INFECTION BACTERIAL 1 0.0037
47 SUSPECTED PRODUCT TAMPERING 2 0.0036
48 DENTAL CARIES 38 0.0034
49 IRREGULAR BREATHING 2 0.0034
50 SYSTEMIC MASTOCYTOSIS 1 0.0033
51 TOOTH EROSION 4 0.0033
52 PUPILLARY LIGHT REFLEX TESTS ABNORMAL 1 0.0032
53 INCREASED DOSE ADMINISTERED 1 0.0032
54 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
55 URINE AMPHETAMINE POSITIVE 1 0.0030
56 YAWNING 8 0.0030
57 PERIPHERAL ISCHAEMIA 12 0.0029
58 FOETAL HYPOKINESIA 2 0.0029
59 ANDROGEN DEFICIENCY 1 0.0028
60 RADIAL NERVE PALSY 1 0.0028
61 CRYOGLOBULINAEMIA 2 0.0028
62 SCHIZOPHRENIA, PARANOID TYPE 1 0.0028
63 CEREBRAL MASS EFFECT 1 0.0028
64 ANKLE ARTHROPLASTY 1 0.0028
65 MULTIPLE DRUG THERAPY 2 0.0027
66 JAUNDICE NEONATAL 5 0.0026
67 ACUTE PHASE REACTION 1 0.0026
68 CEREBELLAR STROKE 1 0.0026
69 HYPERTENSIVE EMERGENCY 3 0.0025
70 DROPPED HEAD SYNDROME 1 0.0025
71 DRUG SCREEN FALSE POSITIVE 7 0.0025
72 SINONASAL OBSTRUCTION 1 0.0025
73 SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY 1 0.0025
74 BASAL GANGLIA HAEMORRHAGE 2 0.0025
75 DRUG WITHDRAWAL HEADACHE 1 0.0024
76 SPINAL DECOMPRESSION 1 0.0024
77 GLUCOCORTICOID DEFICIENCY 1 0.0024
78 DIABETIC HYPEROSMOLAR COMA 1 0.0023
79 GINGIVAL BLISTER 1 0.0023
80 HOMELESS 1 0.0022
81 MANUFACTURING ISSUE 1 0.0022
82 DRUG USE DISORDER 18 0.0021
83 STATUS ASTHMATICUS 1 0.0021
84 PIGMENTARY MACULOPATHY 1 0.0021
85 MYELOID LEUKAEMIA 1 0.0020
86 SALIVARY GLAND ENLARGEMENT 1 0.0019
87 INFUSION SITE CELLULITIS 1 0.0019
88 NON-CARDIOGENIC PULMONARY OEDEMA 2 0.0019
89 DRUG LEVEL ABNORMAL 1 0.0019
90 WITHDRAWAL SYNDROME 79 0.0019
91 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
92 SCROTAL PAIN 1 0.0019
93 HYPERTENSIVE URGENCY 1 0.0018
94 DRUG EFFECT VARIABLE 2 0.0018
95 COLON INJURY 1 0.0017
96 BURN ORAL CAVITY 1 0.0017
97 THOUGHT BLOCKING 1 0.0017
98 BLOOD OESTROGEN INCREASED 1 0.0017
99 NEURODEGENERATIVE DISORDER 1 0.0016
100 DRUG DIVERSION 10 0.0016
101 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 11 0.0016
102 ELBOW OPERATION 1 0.0016
103 BLADDER DISCOMFORT 2 0.0016
104 PROTHROMBIN TIME RATIO DECREASED 1 0.0016
105 BREECH PRESENTATION 2 0.0016
106 HYPERAESTHESIA TEETH 2 0.0016
107 ANION GAP 1 0.0016
108 GINGIVAL DISORDER 6 0.0016
109 SKULL MALFORMATION 1 0.0016
110 ENTEROCOCCUS TEST POSITIVE 1 0.0015
111 SMALL INTESTINE ULCER 1 0.0015
112 GINGIVAL DISCOMFORT 1 0.0015
113 POTENTIATING DRUG INTERACTION 5 0.0015
114 TOOTH FRACTURE 16 0.0014
115 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
116 CARDIAC SEPTAL DEFECT 1 0.0014
117 NASAL INJURY 1 0.0014
118 DENTAL RESTORATION FAILURE 1 0.0014
119 PRODUCT SUBSTITUTION ISSUE 79 0.0014
120 BLUNTED AFFECT 1 0.0014
121 TONGUE BLISTERING 3 0.0013
122 AMPHETAMINES POSITIVE 1 0.0013
123 MICTURITION FREQUENCY DECREASED 1 0.0013
124 INJECTION SITE REACTION 91 0.0013
125 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
126 TOOTH LOSS 26 0.0013
127 RESPIRATORY DISORDER NEONATAL 2 0.0012
128 TONGUE ERYTHEMA 1 0.0012
129 COLLAPSE OF LUNG 1 0.0012
130 STARVATION 1 0.0012
131 COVID-19 IMMUNISATION 1 0.0012
132 OESOPHAGEAL RUPTURE 1 0.0012
133 ENDODONTIC PROCEDURE 3 0.0012
134 INFECTED BITE 1 0.0012
135 DEVICE LOOSENING 1 0.0012
136 VASOCONSTRICTION 1 0.0011
137 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1 0.0011
138 ACUTE CHEST SYNDROME 1 0.0011
139 DRUG SCREEN NEGATIVE 2 0.0011
140 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 7 0.0011
141 SCHIZOAFFECTIVE DISORDER 2 0.0011
142 DRUG DETOXIFICATION 1 0.0011
143 CLONUS 3 0.0011
144 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
145 PRODUCT APPEARANCE CONFUSION 1 0.0011
146 LOBAR PNEUMONIA 2 0.0011
147 PHARYNGEAL HYPOAESTHESIA 1 0.0011
148 ORAL ADMINISTRATION COMPLICATION 1 0.0011
149 PSYCHOMOTOR RETARDATION 3 0.0011
150 PRODUCT AFTER TASTE 1 0.0010
151 CARDIO-RESPIRATORY ARREST 42 0.0010
152 PRODUCT MEASURED POTENCY ISSUE 1 0.0010
153 DILATED CARDIOMYOPATHY 1 0.0010
154 HYPOGONADISM 1 0.0010
155 AUTONOMIC NEUROPATHY 1 0.0010
156 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
157 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
158 DRUG WITHDRAWAL SYNDROME 86 0.0010
159 NON-ALCOHOLIC STEATOHEPATITIS 1 0.0010
160 OEDEMA MUCOSAL 1 0.0010
161 SINUSITIS BACTERIAL 1 0.0009
162 FOETAL DISTRESS SYNDROME 2 0.0009
163 TONGUE DISCOMFORT 4 0.0009
164 PRODUCT COMMINGLING 1 0.0009
165 NEUROMYOPATHY 1 0.0009
166 GALLBLADDER ENLARGEMENT 1 0.0009
167 TOOTH INJURY 4 0.0009
168 PRODUCT NAME CONFUSION 1 0.0009
169 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 1 0.0009
170 CLEFT LIP AND PALATE 1 0.0009
171 OPEN WOUND 1 0.0009
172 HALO VISION 1 0.0009
173 DRUG ABUSE 73 0.0009
174 ADMINISTRATION SITE PAIN 1 0.0009
175 REACTION TO EXCIPIENT 2 0.0009
176 HYPERREFLEXIA 3 0.0009
177 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
178 GLOSSITIS 3 0.0008
179 FEBRILE CONVULSION 1 0.0008
180 DRUG WITHDRAWAL SYNDROME NEONATAL 12 0.0008
181 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0008
182 RENAL ATROPHY 1 0.0008
183 TESTICULAR SWELLING 1 0.0008
184 INFUSION SITE IRRITATION 1 0.0008
185 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
186 ORAL INFECTION 3 0.0008
187 SUSPECTED COUNTERFEIT PRODUCT 3 0.0008
188 FEELING GUILTY 1 0.0008
189 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
190 COLITIS ISCHAEMIC 5 0.0007
191 SUBSTANCE ABUSE 6 0.0007
192 BIPOLAR DISORDER 8 0.0007
193 CLUMSINESS 2 0.0007
194 ACCIDENTAL EXPOSURE 3 0.0007
195 PERIODONTAL DISEASE 1 0.0007
196 HALLUCINATIONS, MIXED 3 0.0007
197 MAST CELL ACTIVATION SYNDROME 1 0.0007
198 RENAL TUBULAR DISORDER 2 0.0007
199 CATAPLEXY 1 0.0007
200 CONNECTIVE TISSUE DISORDER 1 0.0007
201 JUDGEMENT IMPAIRED 1 0.0007
202 STRESS CARDIOMYOPATHY 4 0.0007
203 INTENTIONAL UNDERDOSE 5 0.0007
204 ACUTE ABDOMEN 1 0.0007
205 SEROTONIN SYNDROME 13 0.0007
206 INFUSION SITE INDURATION 1 0.0007
207 IMPETIGO 1 0.0007
208 RESTLESS LEGS SYNDROME 12 0.0007
209 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
210 RESPIRATORY ARREST 18 0.0007
211 RESPIRATORY DEPRESSION 8 0.0007
212 ORAL MUCOSAL ERUPTION 1 0.0007
213 PREMATURE SEPARATION OF PLACENTA 1 0.0006
214 ORAL DISCOMFORT 9 0.0006
215 ORAL MUCOSAL ERYTHEMA 1 0.0006
216 SUBSTANCE USE 1 0.0006
217 ONYCHOLYSIS 1 0.0006
218 TRANSCRIPTION MEDICATION ERROR 1 0.0006
219 EXPOSURE TO TOXIC AGENT 2 0.0006
220 HYPOVENTILATION 2 0.0006
221 THERAPY CHANGE 6 0.0006
222 NEAR DEATH EXPERIENCE 2 0.0006
223 SEBORRHOEIC DERMATITIS 1 0.0006
224 VEIN RUPTURE 1 0.0006
225 RECTAL ABSCESS 1 0.0006
226 TONSILLAR HYPERTROPHY 1 0.0006
227 TOXIC ENCEPHALOPATHY 3 0.0006
228 CEREBELLAR INFARCTION 1 0.0006
229 EUPHORIC MOOD 6 0.0006
230 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
231 PRIAPISM 2 0.0006
232 TONGUE COATED 1 0.0006
233 HYPERAMMONAEMIC ENCEPHALOPATHY 1 0.0006
234 HYPOPITUITARISM 1 0.0006
235 INFUSION SITE DISCHARGE 1 0.0006
236 HANGOVER 2 0.0006
237 RENAL PAIN 6 0.0006
238 POISONING 7 0.0006
239 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
240 PNEUMOMEDIASTINUM 1 0.0006
241 DEVICE ALARM ISSUE 1 0.0006
242 VENOUS OCCLUSION 1 0.0005
243 FAECALOMA 3 0.0005
244 RESTLESSNESS 20 0.0005
245 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
246 HOMICIDE 1 0.0005
247 OESOPHAGEAL SPASM 1 0.0005
248 DISORGANISED SPEECH 1 0.0005
249 ACCIDENTAL DEATH 1 0.0005
250 INSURANCE ISSUE 8 0.0005
251 HYPOREFLEXIA 1 0.0005
252 GINGIVAL RECESSION 1 0.0005
253 CLEFT PALATE 1 0.0005
254 PRODUCT TASTE ABNORMAL 7 0.0005
255 ALCOHOL INTERACTION 1 0.0005
256 FAECES HARD 2 0.0005
257 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
258 PRODUCT DISPENSING ERROR 11 0.0005
259 EMPYEMA 1 0.0005
260 EXPOSURE VIA BREAST MILK 2 0.0005
261 TOOTHACHE 9 0.0005
262 TOOTH EXTRACTION 6 0.0005
263 DILATATION VENTRICULAR 1 0.0005
264 SLEEP DEFICIT 1 0.0005
265 INADEQUATE ANALGESIA 4 0.0005
266 FAECES PALE 1 0.0004
267 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 1 0.0004
268 PRODUCT PHYSICAL ISSUE 9 0.0004
269 PRODUCT USE COMPLAINT 7 0.0004
270 WRONG PRODUCT ADMINISTERED 3 0.0004
271 RENAL COLIC 1 0.0004
272 VASCULAR DEVICE INFECTION 2 0.0004
273 PREMATURE DELIVERY 7 0.0004
274 HYPERHIDROSIS 56 0.0004
275 DYSMORPHISM 1 0.0004
276 PULMONARY INFARCTION 1 0.0004
277 PRE-ECLAMPSIA 2 0.0004
278 SLEEP APNOEA SYNDROME 8 0.0004
279 URINE FLOW DECREASED 1 0.0004
280 PULSE ABNORMAL 1 0.0004
281 STARING 1 0.0004
282 WRONG DOSE 1 0.0004
283 SELF ESTEEM DECREASED 1 0.0004
284 PRODUCT PRESCRIBING ISSUE 9 0.0004
285 PRODUCT PACKAGING CONFUSION 1 0.0004
286 MAJOR DEPRESSION 3 0.0004
287 ORAL DISORDER 3 0.0004
288 SMALL INTESTINAL OBSTRUCTION 5 0.0004
289 DENTAL OPERATION 1 0.0004
290 TOOTH DISORDER 9 0.0004
291 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
292 ACUTE PSYCHOSIS 1 0.0004
293 FEELING DRUNK 3 0.0004
294 SUFFOCATION FEELING 1 0.0004
295 HYPERPARATHYROIDISM SECONDARY 1 0.0004
296 TOXICITY TO VARIOUS AGENTS 67 0.0004
297 COLD SWEAT 7 0.0004
298 MENTAL STATUS CHANGES 11 0.0004
299 MEDICATION RESIDUE 1 0.0004
300 UNRESPONSIVE TO STIMULI 10 0.0004
301 DRUG TITRATION ERROR 1 0.0004
302 BRAIN FOG 6 0.0004
303 CATATONIA 2 0.0004
304 DELIRIUM 13 0.0004
305 ALCOHOL POISONING 1 0.0004
306 COMPLETED SUICIDE 31 0.0004
307 LARYNGOSPASM 1 0.0004
308 EAR CONGESTION 1 0.0004
309 ULCERATIVE KERATITIS 1 0.0004
310 PLEURITIC PAIN 1 0.0004
311 THERAPEUTIC RESPONSE DELAYED 1 0.0004
312 PARAESTHESIA ORAL 5 0.0003
313 EYELID MARGIN CRUSTING 1 0.0003
314 VOMITING PROJECTILE 1 0.0003
315 PRODUCT LABEL CONFUSION 2 0.0003
316 APATHY 5 0.0003
317 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
318 TOOTH DISCOLOURATION 1 0.0003
319 DECREASED INTEREST 2 0.0003
320 INFUSION SITE REACTION 1 0.0003
321 URINE ANALYSIS ABNORMAL 1 0.0003
322 ANAL INCONTINENCE 3 0.0003
323 HYPERCAPNIA 1 0.0003
324 LOSS OF EMPLOYMENT 1 0.0003
325 EMBOLISM VENOUS 1 0.0003
326 DYSCHEZIA 1 0.0003
327 MASTICATION DISORDER 1 0.0003
328 RECTAL CANCER 1 0.0003
329 FIBROSIS 1 0.0003
330 RHINORRHOEA 21 0.0003
331 MULTIPLE-DRUG RESISTANCE 1 0.0003
332 ILEUS 4 0.0003
333 INTENTIONAL PRODUCT USE ISSUE 28 0.0003
334 BLOOD CREATININE DECREASED 1 0.0003
335 NON-CARDIAC CHEST PAIN 1 0.0003
336 THERAPEUTIC RESPONSE CHANGED 2 0.0003
337 MYDRIASIS 4 0.0003
338 SOMNAMBULISM 2 0.0003
339 INFUSION SITE HAEMORRHAGE 1 0.0003
340 TOOTH INFECTION 4 0.0003
341 PRODUCT FORMULATION ISSUE 2 0.0003
342 TONGUE ULCERATION 1 0.0003
343 PRODUCT LABEL ISSUE 2 0.0003
344 CERVICAL VERTEBRAL FRACTURE 1 0.0003
345 EXPOSURE DURING PREGNANCY 18 0.0003
346 HYPOPNOEA 1 0.0003
347 EXTRASYSTOLES 2 0.0003
348 THROMBOPHLEBITIS 1 0.0003
349 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
350 PRODUCT CONTAMINATION 1 0.0003
351 HAEMORRHAGIC DIATHESIS 1 0.0003
352 APPARENT DEATH 1 0.0003
353 TONGUE DISORDER 2 0.0003
354 MONOCYTE COUNT INCREASED 1 0.0003
355 HYPOMANIA 1 0.0003
356 PSYCHIATRIC SYMPTOM 2 0.0003
357 CEREBRAL DISORDER 2 0.0003
358 ORAL PAIN 6 0.0003
359 SKIN INFECTION 3 0.0003
360 INTESTINAL PERFORATION 3 0.0003
361 IMPULSIVE BEHAVIOUR 1 0.0003
362 PARANASAL SINUS DISCOMFORT 1 0.0003
363 PRODUCT STORAGE ISSUE 1 0.0003
364 DRUG DEPENDENCE 42 0.0003
365 CLAVICLE FRACTURE 1 0.0003
366 CONCUSSION 2 0.0003
367 PANIC DISORDER 1 0.0003
368 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
369 CARDIOPULMONARY FAILURE 1 0.0003
370 TORSADE DE POINTES 2 0.0003
371 NAIL DISCOLOURATION 1 0.0003
372 CYANOSIS 4 0.0003
373 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
374 MIOSIS 2 0.0002
375 TRIGEMINAL NEURALGIA 1 0.0002
376 FUNGAL SKIN INFECTION 1 0.0002
377 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
378 HOMICIDAL IDEATION 1 0.0002
379 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
380 ARTHRITIS BACTERIAL 1 0.0002
381 HICCUPS 2 0.0002
382 HYPERAESTHESIA 2 0.0002
383 SELF-MEDICATION 1 0.0002
384 LEG AMPUTATION 1 0.0002
385 SOCIAL PROBLEM 1 0.0002
386 EOSINOPHIL COUNT INCREASED 2 0.0002
387 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
388 HALLUCINATION, VISUAL 5 0.0002
389 MUSCLE FATIGUE 1 0.0002
390 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
391 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
392 FACIAL PARALYSIS 2 0.0002
393 SHOULDER OPERATION 1 0.0002
394 ALCOHOLISM 1 0.0002
395 AGITATION 17 0.0002
396 STOMATITIS 14 0.0002
397 CARDIAC ARREST 19 0.0002
398 IMMOBILE 1 0.0002
399 TONGUE DISCOLOURATION 1 0.0002
400 GINGIVAL SWELLING 1 0.0002
401 WHEELCHAIR USER 1 0.0002
402 ILEUS PARALYTIC 1 0.0002
403 SUSPECTED OFF LABEL USE 1 0.0002
404 PRODUCT QUALITY ISSUE 30 0.0002
405 TACHYPNOEA 3 0.0002
406 URINE ABNORMALITY 1 0.0002
407 HIDRADENITIS 2 0.0002
408 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
409 IMMUNE THROMBOCYTOPENIA 1 0.0002
410 DRUG INTOLERANCE 21 0.0002
411 INCREASED TENDENCY TO BRUISE 2 0.0002
412 MUSCLE TWITCHING 5 0.0002
413 IRON DEFICIENCY ANAEMIA 2 0.0002
414 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
415 LOCALISED OEDEMA 1 0.0002
416 NEPHROGENIC ANAEMIA 1 0.0002
417 RHABDOMYOLYSIS 9 0.0002
418 DEMENTIA 6 0.0002
419 THINKING ABNORMAL 4 0.0002
420 ROSACEA 1 0.0002
421 FEELING OF DESPAIR 1 0.0002
422 NEPHROPATHY 2 0.0002
423 SUSPECTED SUICIDE 1 0.0002
424 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 43 0.0002
425 VOMITING 99 0.0002
426 FEELING JITTERY 4 0.0002
427 ENDOMETRIOSIS 1 0.0002
428 HYPERSOMNIA 6 0.0002
429 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
430 SUBCUTANEOUS ABSCESS 1 0.0002
431 LETHARGY 12 0.0002
432 FAECAL INCONTINENCE 1 0.0002
433 HUMERUS FRACTURE 1 0.0002
434 SINUS BRADYCARDIA 2 0.0002
435 RASH VESICULAR 1 0.0002
436 CHILLS 24 0.0002
437 INCORRECT DOSAGE ADMINISTERED 1 0.0002
438 APPLICATION SITE BURN 1 0.0002
439 PANCREATIC DISORDER 1 0.0002
440 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
441 SKIN HAEMORRHAGE 3 0.0002
442 EXPIRED DRUG ADMINISTERED 1 0.0002
443 INFLAMMATORY MARKER INCREASED 1 0.0002
444 MULTIPLE DRUG OVERDOSE 1 0.0002
445 HEPATIC ENZYME ABNORMAL 1 0.0002
446 FLUID INTAKE REDUCED 1 0.0002
447 BRAIN INJURY 2 0.0002
448 TASTE DISORDER 4 0.0002
449 NAUSEA 156 0.0002
450 FOETAL EXPOSURE DURING PREGNANCY 16 0.0002
451 ANXIETY 56 0.0002
452 SUBARACHNOID HAEMORRHAGE 2 0.0002
453 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
454 ENDOCARDITIS 1 0.0002
455 PRODUCT COLOUR ISSUE 1 0.0002
456 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
457 ILLNESS 20 0.0002
458 TRISMUS 1 0.0002
459 APLASTIC ANAEMIA 1 0.0002
460 SENSITIVITY TO WEATHER CHANGE 1 0.0002
461 RETCHING 4 0.0002
462 ANAL FISTULA 1 0.0002
463 FOOD POISONING 1 0.0002
464 PRODUCT SIZE ISSUE 1 0.0002
465 POOR QUALITY SLEEP 4 0.0002
466 SUICIDAL IDEATION 17 0.0002
467 BRUXISM 1 0.0002
468 GINGIVITIS 1 0.0002
469 BEHAVIOUR DISORDER 1 0.0002
470 PHARYNGITIS STREPTOCOCCAL 2 0.0002
471 SKIN LACERATION 2 0.0002
472 IRRITABILITY 11 0.0002
473 THERAPEUTIC RESPONSE DECREASED 11 0.0002
474 CHOKING SENSATION 1 0.0002
475 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
476 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
477 FEELING COLD 5 0.0002
478 HEART RATE ABNORMAL 1 0.0002
479 MALNUTRITION 2 0.0002
480 PRODUCT LEAKAGE 1 0.0002
481 OVERDOSE 38 0.0002
482 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
483 EXTRA DOSE ADMINISTERED 7 0.0002
484 HYPERVENTILATION 1 0.0002
485 DYSKINESIA 7 0.0002
486 HEAD DISCOMFORT 3 0.0002
487 ENERGY INCREASED 1 0.0002
488 ODYNOPHAGIA 1 0.0002
489 PROTHROMBIN TIME PROLONGED 1 0.0002
490 HEPATITIS C 2 0.0002
491 FIBROMYALGIA 4 0.0002
492 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
493 ACCIDENTAL OVERDOSE 6 0.0002
494 GENERALISED OEDEMA 2 0.0002
495 MIDDLE INSOMNIA 3 0.0002
496 INFUSION SITE EXTRAVASATION 1 0.0002
497 PRE-EXISTING CONDITION IMPROVED 1 0.0002
498 SWOLLEN TONGUE 5 0.0002
499 SOMNOLENCE 32 0.0002
500 HYPOPHAGIA 4 0.0002
501 ENTERITIS 1 0.0002
502 INFUSION SITE PAIN 2 0.0002
503 DYSTONIA 3 0.0002
504 INJECTION SITE INDURATION 2 0.0002
505 HEPATITIS ACUTE 1 0.0002
506 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
507 SEDATION 4 0.0002
508 PRODUCT PREPARATION ISSUE 1 0.0002
509 ORAL CANDIDIASIS 2 0.0002
510 IMMUNE SYSTEM DISORDER 2 0.0002
511 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 27 0.0001
512 POST-TRAUMATIC STRESS DISORDER 1 0.0001
513 QUALITY OF LIFE DECREASED 2 0.0001
514 INTENTIONAL PRODUCT MISUSE 13 0.0001
515 ULCER HAEMORRHAGE 1 0.0001
516 DRUG TOXICITY 2 0.0001
517 ABNORMAL LOSS OF WEIGHT 1 0.0001
518 AKATHISIA 2 0.0001
519 GINGIVAL BLEEDING 2 0.0001
520 BLOOD TESTOSTERONE DECREASED 1 0.0001
521 EYE MOVEMENT DISORDER 1 0.0001
522 GASTROINTESTINAL DISORDER 13 0.0001
523 DRUG INTERACTION 23 0.0001
524 TREATMENT FAILURE 12 0.0001
525 ENCEPHALITIS 1 0.0001
526 LARGE INTESTINE PERFORATION 1 0.0001
527 FORMICATION 1 0.0001
528 HUNGER 2 0.0001
529 INTENTIONAL DRUG MISUSE 3 0.0001
530 ROAD TRAFFIC ACCIDENT 6 0.0001
531 COORDINATION ABNORMAL 2 0.0001
532 APPLICATION SITE REACTION 1 0.0001
533 DEVICE OCCLUSION 2 0.0001
534 FEELING ABNORMAL 34 0.0001
535 SEASONAL ALLERGY 2 0.0001
536 THERMAL BURN 1 0.0001
537 JOINT INJURY 3 0.0001
538 PRODUCT SUPPLY ISSUE 1 0.0001
539 AGGRESSION 7 0.0001
540 CARDIOGENIC SHOCK 2 0.0001
541 IMPAIRED QUALITY OF LIFE 2 0.0001
542 INSOMNIA 37 0.0001
543 TREMOR 23 0.0001
544 RASH PUSTULAR 1 0.0001
545 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
546 DYSSTASIA 4 0.0001
547 BONE PAIN 8 0.0001
548 DYSURIA 5 0.0001
549 DRY MOUTH 11 0.0001
550 HEADACHE 85 0.0001
551 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
552 SUNBURN 1 0.0001
553 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
554 HYPOAESTHESIA ORAL 2 0.0001
555 APHASIA 4 0.0001
556 ECONOMIC PROBLEM 2 0.0001
557 HYPERTHERMIA 1 0.0001
558 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
559 FOOD ALLERGY 1 0.0001
560 PELVIC FRACTURE 1 0.0001
561 THERAPY PARTIAL RESPONDER 2 0.0001
562 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
563 DRUG SCREEN POSITIVE 1 0.0001
564 PRODUCT PRESCRIBING ERROR 3 0.0001
565 LOW BIRTH WEIGHT BABY 1 0.0001
566 GINGIVAL PAIN 1 0.0001
567 ABSCESS 2 0.0001
568 UTERINE CANCER 1 0.0001
569 MYASTHENIA GRAVIS 1 0.0001
570 FRUSTRATION TOLERANCE DECREASED 1 0.0001
571 POST PROCEDURAL INFECTION 1 0.0001
572 POLYURIA 1 0.0001
573 MANIA 2 0.0001
574 MENSTRUAL DISORDER 1 0.0001
575 EMBOLISM 1 0.0001
576 LIP SWELLING 4 0.0001
577 LIVE BIRTH 1 0.0001
578 HOT FLUSH 9 0.0001
579 SENSATION OF FOREIGN BODY 1 0.0001
580 INFUSION SITE ERYTHEMA 1 0.0001
581 ANGER 4 0.0001
582 HEMIPARESIS 2 0.0001
583 SKIN HYPERPIGMENTATION 1 0.0001
584 PARANOIA 2 0.0001
585 NIGHTMARE 4 0.0001
586 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
587 NAIL DISORDER 1 0.0001
588 BLOOD CALCIUM INCREASED 1 0.0001
589 DEPRESSED MOOD 6 0.0001
590 ABDOMINAL DISCOMFORT 19 0.0001
591 LUNG INFILTRATION 1 0.0001
592 RESPIRATORY RATE INCREASED 1 0.0001
593 TACHYCARDIA 10 0.0001
594 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
595 GASTROINTESTINAL INFECTION 1 0.0001
596 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
597 CONFUSIONAL STATE 18 0.0001
598 HEART RATE INCREASED 11 0.0001
599 GASTROENTERITIS VIRAL 2 0.0001
600 LEUKOCYTOSIS 2 0.0001
601 OSTEOMYELITIS 2 0.0001
602 DRUG EFFECT INCOMPLETE 4 0.0001
603 PANIC ATTACK 4 0.0001
604 INFLUENZA LIKE ILLNESS 9 0.0001
605 PERSONALITY CHANGE 1 0.0001
606 WOUND 3 0.0001
607 APPENDICITIS 1 0.0001
608 DEFORMITY 1 0.0001
609 FLANK PAIN 1 0.0001
610 LACERATION 1 0.0001
611 DYSPNOEA EXERTIONAL 4 0.0001
612 DEPRESSION 24 0.0001
613 BLOOD URINE PRESENT 2 0.0001
614 PRODUCT PACKAGING ISSUE 1 0.0001
615 INTENTIONAL DOSE OMISSION 3 0.0001
616 PRESCRIBED OVERDOSE 2 0.0001
617 EAR PAIN 2 0.0001
618 VITAMIN D DEFICIENCY 1 0.0001
619 PHARYNGEAL SWELLING 1 0.0001
620 COELIAC DISEASE 1 0.0001
621 KNEE OPERATION 1 0.0001
622 LOSS OF CONSCIOUSNESS 13 0.0001
623 BLADDER DISORDER 1 0.0001
624 UPPER LIMB FRACTURE 2 0.0001
625 MALAISE 44 0.0001
626 HYPOTONIA 1 0.0001
627 SALIVARY HYPERSECRETION 1 0.0001
628 BURNING SENSATION 7 0.0001
629 PREMATURE BABY 3 0.0001
630 LACRIMATION INCREASED 3 0.0001
631 PRODUCT ADMINISTRATION ERROR 2 0.0001
632 FEEDING DISORDER 2 0.0001
633 FLUSHING 10 0.0001
634 DRUG LEVEL DECREASED 1 0.0001
635 TOOTH ABSCESS 1 0.0001
636 EAR DISCOMFORT 1 0.0001
637 INFLAMMATION 5 0.0001
638 POOR VENOUS ACCESS 1 0.0001
639 NERVOUSNESS 5 0.0001
640 PRODUCT ODOUR ABNORMAL 1 0.0001
641 TRANSFUSION 1 0.0001
642 MOUTH ULCERATION 2 0.0001
643 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
644 MYALGIA 16 0.0001
645 EATING DISORDER 2 0.0001
646 NIGHT SWEATS 3 0.0001
647 INCORRECT DOSE ADMINISTERED 21 0.0001
648 MENTAL DISORDER 4 0.0001
649 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
650 TREATMENT NONCOMPLIANCE 5 0.0001
651 GASTROINTESTINAL PAIN 1 0.0001
652 FOOT DEFORMITY 1 0.0001
653 URINARY RETENTION 3 0.0001
654 PAIN 55 0.0001
655 NECK PAIN 5 0.0001
656 GLOSSODYNIA 2 0.0001
657 THROAT IRRITATION 4 0.0001
658 THERAPY NON-RESPONDER 4 0.0001
659 IMPAIRED DRIVING ABILITY 1 0.0001
660 DERMATITIS CONTACT 1 0.0001
661 SCAB 1 0.0001
662 CONVULSION 5 0.0001
663 VISION BLURRED 12 0.0001
664 HYPOKALAEMIA 4 0.0001
665 SEIZURE 10 0.0001
666 OROPHARYNGEAL PAIN 8 0.0001
667 DIZZINESS 43 0.0001
668 CAESAREAN SECTION 1 0.0001
669 VASCULITIS 1 0.0001
670 HEART RATE DECREASED 3 0.0001
671 SURGERY 5 0.0001
672 HYPOXIA 3 0.0001
673 ATAXIA 1 0.0001
674 THERAPY INTERRUPTED 6 0.0001
675 MUSCLE RIGIDITY 1 0.0001
676 WRIST FRACTURE 1 0.0001
677 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
678 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
679 CONSTIPATION 18 0.0001
680 MENTAL IMPAIRMENT 2 0.0001
681 ADRENAL INSUFFICIENCY 1 0.0001
682 MUSCLE SPASMS 15 0.0001
683 SYNCOPE 8 0.0001
684 DRUG INEFFECTIVE 105 0.0001
685 ABDOMINAL PAIN LOWER 2 0.0001
686 PRODUCT COMPLAINT 2 0.0001
687 CHEST DISCOMFORT 8 0.0001
688 ADVERSE DRUG REACTION 7 0.0001
689 THERAPY CESSATION 4 0.0001
690 PALPITATIONS 9 0.0001
691 INCORRECT PRODUCT STORAGE 1 0.0001
692 BEDRIDDEN 1 0.0001
693 GASTRITIS 2 0.0001
694 ADVERSE EVENT 7 0.0001
695 HYPERSENSITIVITY 14 0.0001
696 ADVERSE REACTION 1 0.0001
697 PAIN OF SKIN 2 0.0001
698 DRUG EFFECT DECREASED 4 0.0001
699 DISTURBANCE IN ATTENTION 4 0.0001
700 SINUS CONGESTION 1 0.0001
701 OEDEMA 4 0.0001
702 PALLOR 2 0.0001
703 MOOD ALTERED 2 0.0001
704 DEPENDENCE 4 0.0001
705 PERIPHERAL COLDNESS 1 0.0001
706 ABNORMAL DREAMS 2 0.0001
707 MEDICATION ERROR 4 0.0001
708 PRODUCT DOSE OMISSION ISSUE 21 0.0001
709 BLOOD TEST ABNORMAL 1 0.0001
710 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
711 PAIN IN JAW 2 0.0001
712 FLATULENCE 4 0.0001
713 BALANCE DISORDER 6 0.0001
714 HYPOKINESIA 1 0.0001
715 DYSPHONIA 4 0.0001
716 ABDOMINAL PAIN UPPER 14 0.0001
717 ACUTE MYOCARDIAL INFARCTION 2 0.0001
718 LIVER DISORDER 3 0.0001
719 URINARY INCONTINENCE 2 0.0001
720 DYSGEUSIA 5 0.0001
721 PULMONARY OEDEMA 3 0.0001
722 HAEMORRHAGE INTRACRANIAL 1 0.0001
723 EPISTAXIS 5 0.0001
724 BONE LOSS 1 0.0001
725 HALLUCINATION 5 0.0001
726 ACUTE KIDNEY INJURY 10 0.0001
727 TINNITUS 3 0.0001
728 SKIN DISCOLOURATION 3 0.0001
729 DEVICE ADHESION ISSUE 1 0.0001
730 PHARYNGEAL OEDEMA 1 0.0001
731 EMOTIONAL DISORDER 2 0.0001
732 MUSCULOSKELETAL CHEST PAIN 1 0.0001
733 TENDONITIS 1 0.0001
734 RENAL DISORDER 3 0.0001
735 EJECTION FRACTION DECREASED 1 0.0001
736 COGNITIVE DISORDER 3 0.0001
737 DISEASE RECURRENCE 3 0.0001
738 HALLUCINATION, AUDITORY 1 0.0001
739 MIGRAINE 6 0.0001
740 MOOD SWINGS 2 0.0001
741 MOVEMENT DISORDER 2 0.0001
742 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
743 OFF LABEL USE 54 0.0001
744 BLOOD POTASSIUM INCREASED 1 0.0001
745 BACK DISORDER 1 0.0001
746 AMNESIA 4 0.0001
747 PAIN IN EXTREMITY 18 0.0001
748 DYSPEPSIA 6 0.0001
749 PHOTOSENSITIVITY REACTION 1 0.0001
750 VIRAL INFECTION 2 0.0001
751 BLOOD UREA INCREASED 1 0.0001
752 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
753 FACE OEDEMA 1 0.0001
754 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
755 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
756 ASTHENIA 22 0.0001
757 SCAR 1 0.0001
758 DYSPNOEA 33 0.0001
759 MUSCULOSKELETAL DISCOMFORT 1 0.0001
760 WEIGHT INCREASED 13 0.0001
761 WEIGHT DECREASED 16 0.0001
762 SLEEP DISORDER 4 0.0001
763 HYPERTENSION 12 0.0001
764 BRADYCARDIA 3 0.0001
765 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
766 DECREASED APPETITE 13 0.0001
767 BACK PAIN 13 0.0001
768 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
769 CRYING 2 0.0001
770 BLOOD GLUCOSE ABNORMAL 1 0.0001
771 HEPATIC FUNCTION ABNORMAL 2 0.0001
772 SWELLING 5 0.0001
773 BLISTER 3 0.0001
774 HEPATIC CIRRHOSIS 1 0.0001
775 PRODUCT USE ISSUE 10 0.0001
776 DYSARTHRIA 2 0.0001
777 BLOOD SODIUM DECREASED 1 0.0001
778 FOOT FRACTURE 1 0.0001
779 DEHYDRATION 7 0.0001
780 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
781 EYE IRRITATION 3 0.0001
782 POST PROCEDURAL COMPLICATION 1 0.0001
783 PERIPHERAL SWELLING 8 0.0001
784 SKIN FISSURES 1 0.0001
785 KIDNEY INFECTION 1 0.0001
786 MENORRHAGIA 1 0.0001
787 DISABILITY 1 0.0001
788 ABNORMAL BEHAVIOUR 2 0.0001
789 DISORIENTATION 2 0.0001
790 PREGNANCY 1 0.0000
791 SUICIDE ATTEMPT 3 0.0000
792 ILL-DEFINED DISORDER 3 0.0000
793 OEDEMA PERIPHERAL 6 0.0000
794 DISCOMFORT 3 0.0000
795 SINUSITIS 5 0.0000
796 RIB FRACTURE 1 0.0000
797 CHEST PAIN 9 0.0000
798 DIARRHOEA 31 0.0000
799 INTENTIONAL OVERDOSE 3 0.0000
800 FAECES DISCOLOURED 1 0.0000
801 DEVICE DISLOCATION 2 0.0000
802 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
803 SNEEZING 1 0.0000
804 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
805 HEART RATE IRREGULAR 1 0.0000
806 PRODUCT AVAILABILITY ISSUE 1 0.0000
807 SKIN IRRITATION 2 0.0000
808 NEPHROLITHIASIS 2 0.0000
809 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
810 ABDOMINAL PAIN 10 0.0000
811 INJURY 3 0.0000
812 FATIGUE 33 0.0000
813 URTICARIA 7 0.0000
814 MOBILITY DECREASED 3 0.0000
815 BLOOD PRESSURE FLUCTUATION 1 0.0000
816 PRURITUS 16 0.0000
817 EMOTIONAL DISTRESS 5 0.0000
818 RESPIRATORY FAILURE 3 0.0000
819 PRESYNCOPE 1 0.0000
820 LUNG DISORDER 2 0.0000
821 LIVER INJURY 1 0.0000
822 ENCEPHALOPATHY 1 0.0000
823 OSTEONECROSIS OF JAW 1 0.0000
824 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
825 AGEUSIA 1 0.0000
826 PNEUMONIA ASPIRATION 1 0.0000
827 HYPOTENSION 8 0.0000
828 CELLULITIS 2 0.0000
829 GASTRIC CANCER 1 0.0000
830 CONDITION AGGRAVATED 12 0.0000
831 HAEMATEMESIS 1 0.0000
832 BLOOD PRESSURE INCREASED 6 0.0000
833 HEPATITIS 1 0.0000
834 FALL 13 0.0000
835 HOSPITALISATION 6 0.0000
836 ERECTILE DYSFUNCTION 1 0.0000
837 RESPIRATORY TRACT INFECTION 1 0.0000
838 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
839 DEAFNESS 1 0.0000
840 PANCREATITIS 2 0.0000
841 EAR INFECTION 1 0.0000
842 DRY SKIN 5 0.0000
843 FEAR 1 0.0000
844 BLOOD BILIRUBIN INCREASED 1 0.0000
845 THROAT TIGHTNESS 1 0.0000
846 LIMB INJURY 1 0.0000
847 SKIN LESION 1 0.0000
848 HAEMOPTYSIS 1 0.0000
849 PANCYTOPENIA 2 0.0000
850 OXYGEN SATURATION DECREASED 2 0.0000
851 EYE PAIN 2 0.0000
852 TARDIVE DYSKINESIA 1 0.0000
853 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
854 PYREXIA 12 0.0000
855 INFECTION 5 0.0000
856 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
857 PNEUMONIA 11 0.0000
858 LABORATORY TEST ABNORMAL 1 0.0000
859 PSYCHOTIC DISORDER 1 0.0000
860 ARTHRALGIA 14 0.0000
861 RENAL INJURY 1 0.0000
862 RESPIRATORY DISORDER 1 0.0000
863 HYPOAESTHESIA 5 0.0000
864 HEPATIC FAILURE 1 0.0000
865 FEELING HOT 2 0.0000
866 INJECTION SITE RASH 1 0.0000
867 DEATH 28 0.0000
868 LIMB DISCOMFORT 1 0.0000
869 RASH 14 0.0000
870 CARDIAC DISORDER 3 0.0000
871 NERVOUS SYSTEM DISORDER 1 0.0000
872 HEAD INJURY 1 0.0000
873 NEUROPATHY PERIPHERAL 3 0.0000
874 HYPOTHYROIDISM 1 0.0000
875 METABOLIC ACIDOSIS 1 0.0000
876 HIP FRACTURE 1 0.0000
877 SWELLING FACE 2 0.0000
878 CHOLELITHIASIS 1 0.0000
879 EYE DISORDER 1 0.0000
880 STAPHYLOCOCCAL INFECTION 1 0.0000
881 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
882 BLOOD PRESSURE DECREASED 2 0.0000
883 EXPIRED PRODUCT ADMINISTERED 1 0.0000
884 SKIN DISORDER 1 0.0000
885 NEOPLASM MALIGNANT 2 0.0000
886 GAIT INABILITY 1 0.0000
887 EYE PRURITUS 1 0.0000
888 TYPE 2 DIABETES MELLITUS 1 0.0000
889 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
890 HAEMATURIA 1 0.0000
891 GASTRIC DISORDER 1 0.0000
892 DEVICE USE ERROR 1 0.0000
893 ABDOMINAL DISTENSION 3 0.0000
894 COVID-19 5 0.0000
895 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
896 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
897 PRODUCT ADHESION ISSUE 1 0.0000
898 SKIN BURNING SENSATION 2 0.0000
899 MYELOSUPPRESSION 1 0.0000
900 C-REACTIVE PROTEIN INCREASED 1 0.0000
901 UNDERDOSE 2 0.0000
902 UNEVALUABLE EVENT 2 0.0000
903 RHEUMATOID ARTHRITIS 3 0.0000
904 COLITIS 1 0.0000
905 CHRONIC KIDNEY DISEASE 2 0.0000
906 ANAEMIA 5 0.0000
907 GAIT DISTURBANCE 5 0.0000
908 ALOPECIA 5 0.0000
909 ARTHRITIS 2 0.0000
910 ABORTION SPONTANEOUS 1 0.0000
911 PSORIATIC ARTHROPATHY 1 0.0000
912 BLINDNESS 1 0.0000
913 LUNG NEOPLASM MALIGNANT 1 0.0000
914 VISUAL IMPAIRMENT 3 0.0000
915 RENAL IMPAIRMENT 2 0.0000
916 SKIN EXFOLIATION 2 0.0000
917 OSTEOARTHRITIS 1 0.0000
918 RENAL FAILURE ACUTE 1 0.0000
919 DEVICE LEAKAGE 1 0.0000
920 MUSCULOSKELETAL STIFFNESS 2 0.0000
921 ANGIOEDEMA 1 0.0000
922 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
923 COUGH 6 0.0000
924 OCULAR HYPERAEMIA 1 0.0000
925 DYSPHAGIA 2 0.0000
926 PULMONARY EMBOLISM 2 0.0000
927 COMA 1 0.0000
928 PRODUCTIVE COUGH 1 0.0000
929 CONTUSION 2 0.0000
930 HYPOGLYCAEMIA 1 0.0000
931 FLUID RETENTION 1 0.0000
932 ECZEMA 1 0.0000
933 SPEECH DISORDER 1 0.0000
934 PARAESTHESIA 3 0.0000
935 DERMATITIS ATOPIC 1 0.0000
936 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
937 PLATELET COUNT DECREASED 2 0.0000
938 RASH PRURITIC 1 0.0000
939 HAEMATOCHEZIA 1 0.0000
940 INFLUENZA 2 0.0000
941 SEPSIS 2 0.0000
942 HYPONATRAEMIA 1 0.0000
943 ASTHMA 2 0.0000
944 MUSCULAR WEAKNESS 2 0.0000
945 URINARY TRACT INFECTION 3 0.0000
946 HERPES ZOSTER 1 0.0000
947 MYOCARDIAL INFARCTION 3 0.0000
948 NASAL CONGESTION 1 0.0000
949 WHEEZING 1 0.0000
950 CATARACT 1 0.0000
951 JOINT SWELLING 2 0.0000
952 PLEURAL EFFUSION 1 0.0000
953 VERTIGO 1 0.0000
954 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
955 INJECTION SITE ERYTHEMA 2 0.0000
956 BLOOD GLUCOSE INCREASED 3 0.0000
957 DEEP VEIN THROMBOSIS 1 0.0000
958 PRODUCT DOSE OMISSION 1 0.0000
959 BLOOD CREATININE INCREASED 1 0.0000
960 PSORIASIS 2 0.0000
961 INFUSION RELATED REACTION 1 0.0000
962 FEBRILE NEUTROPENIA 1 0.0000
963 NEUTROPENIA 2 0.0000
964 HEPATIC ENZYME INCREASED 1 0.0000
965 ERYTHEMA 3 0.0000
966 MEMORY IMPAIRMENT 2 0.0000
967 BRONCHITIS 1 0.0000
968 INJECTION SITE SWELLING 1 0.0000
969 CARDIAC FAILURE 1 0.0000
970 CARDIAC FAILURE CONGESTIVE 1 0.0000
971 THROMBOSIS 1 0.0000
972 DRUG DOSE OMISSION 2 0.0000
973 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
974 CEREBROVASCULAR ACCIDENT 2 0.0000
975 PRODUCT STORAGE ERROR 1 0.0000
976 DEVICE ISSUE 1 0.0000
977 NO ADVERSE EVENT 2 0.0000
978 NASOPHARYNGITIS 2 0.0000
979 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
980 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
981 RENAL FAILURE 1 0.0000
982 INJECTION SITE PAIN 2 0.0000